European Commission, and Solar Impulse Foundation have partnered to launch an initiative supporting small and medium-sized ...

(IN BRIEF) Flemish water utility De Watergroep has secured a €350 million loan from the European Investment Bank (EIB) to ...

OMRON Healthcare has secured De Novo authorisation from the US Food and Drug Administration (FDA) for new home blood pressure ...

Researchers at New York University have devised a mathematical approach to predict the structures of crystals—a critical step in developing many medicines and electronic devices—in a matter of ...

OMRON Healthcare has received de novo authorization from the U.S. Food and Drug Administration (FDA) to market new home blood pressure monitors featuring AI-powered atrial fibrillation ...

In a pivotal stride to address the growing AFib epidemic, OMRON Healthcare today announced the U.S. Food and Drug ...

Capucia Publishing is proud to introduce Quantum Rebel, the latest book by Chindia Ilonka, a global leader in human transformation and organizational effectiveness. In this powerful new release, ...

OneCause, a leading provider of digital fundraising technology, announced that the ninth annual Raise conference will take place on the Riverwalk in San Antonio, TX, on September 8-9, 2025. The event ...

The FDA has granted a de novo clearance to a wearable device—with a form factor you’re familiar with—that can check patients ...

OMRON offers an array of products, including OMRON Complete, which combines blood pressure monitoring with ECG to detect heart irregularities like AFib, tachycardia, and hypertension. Through the ...

Founded by Kazuma Tateishi, OMRON’s mission has always been about empowering people to take charge of their health. The company has spent over 50 years developing innovative solutions for ...

Atrial fibrillation (AFib) is an irregular and often rapid heart rhythm. The terms “controlled AFib” and “uncontrolled AFib” describe whether treatment strategies are effectively managing ...